{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T22:30:00Z","timestamp":1788388200976,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T00:00:00Z","timestamp":1597017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T00:00:00Z","timestamp":1597017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008322","name":"CSL Behring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Subcutaneous immunoglobulin (SCIG) is increasingly utilized in primary immunodeficiency (PI). Understanding factors associated with treatment experience and satisfaction can optimize patient outcomes. We analyzed Immune Deficiency Foundation (IDF) survey data to evaluate patient-reported outcomes (PROs) in relation to SCIG training and infusion characteristics. Respondents\u2019 PRO scores were rank ordered into \u2018best\u2019, \u2018intermediate\u2019, and \u2018worst\u2019 tertiles. Predicted probabilities of being in the best tertile with any combination of characteristics were generated for each PRO.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>In 366 SCIG respondents, higher odds of being in the best PRO tertile were\u00a0driven by favorable training characteristics (particularly, higher confidence post-training and no training barriers) and efficient infusions (infusion preparation \u226420\u2009min and actual infusion &lt;\u20092\u2009h). Age (\u226417\u2009years old) and treatment experience (&gt;\u20092\u2009years) increased the odds of being in the best tertiles. Compared with the least favorable training\/infusion characteristics, those with the most favorable training\/infusion characteristics had higher predicted probabilities of being in the best tertiles: TSQM <jats:italic>side effects<\/jats:italic>, 59% vs 4%; <jats:italic>convenience<\/jats:italic>, 52% vs 4%; <jats:italic>effectiveness<\/jats:italic>, 27% vs 13%; <jats:italic>global<\/jats:italic>, 26% vs 3%; PROMIS Fatigue, 44% vs 18%.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Increased experience with SCIG consistently improved PROs, but our findings predicted that enhanced training and infusion characteristics improve patient treatment satisfaction beyond that achieved by experience alone.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12865-020-00371-y","type":"journal-article","created":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T17:03:48Z","timestamp":1597079028000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Subcutaneous immunoglobulin in primary immunodeficiency \u2013 impact of training and infusion characteristics on patient-reported outcomes"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0273-9680","authenticated-orcid":false,"given":"R.","family":"Mallick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. J.","family":"Lahue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kafal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Bassett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Scalchunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,10]]},"reference":[{"key":"371_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13223-015-0092-y","volume":"11","author":"F Jiang","year":"2015","unstructured":"Jiang F, Torgerson TR, Ayars AG. Health-related quality of life in patients with primary immunodeficiency disease. Allergy, Asthma Clin Immunol. 2015;11:27. https:\/\/doi.org\/10.1186\/s13223-015-0092-y.","journal-title":"Allergy, Asthma Clin Immunol"},{"issue":"1","key":"371_CR2","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s10875-017-0464-9","volume":"38","author":"C Picard","year":"2018","unstructured":"Picard C, Bobby Gaspar H, Al-Herz W, et al. International Union of Immunological Societies: 2017 primary immunodeficiency diseases committee report on inborn errors of immunity. J Clin Immunol. 2018;38(1):96\u2013128. https:\/\/doi.org\/10.1007\/s10875-017-0464-9.","journal-title":"J Clin Immunol"},{"key":"371_CR3","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jaut.2019.01.011","volume":"99","author":"L Amaya-Uribe","year":"2019","unstructured":"Amaya-Uribe L, Rojas M, Azizi G, et al. Primary immunodeficiency and autoimmunity: a comprehensive review. J Autoimmun. 2019;99:52\u201372. https:\/\/doi.org\/10.1016\/j.jaut.2019.01.011.","journal-title":"J Autoimmun"},{"issue":"5","key":"371_CR4","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s10875-007-9103-1","volume":"27","author":"JM Boyle","year":"2007","unstructured":"Boyle JM, Buckley RH. Population prevalence of diagnosed primary immunodeficiency diseases in the United States. J Clin Immunol. 2007;27(5):497\u2013502. https:\/\/doi.org\/10.1007\/s10875-007-9103-1.","journal-title":"J Clin Immunol"},{"issue":"12","key":"371_CR5","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1080\/17425247.2018.1546692","volume":"15","author":"AR Kafal","year":"2018","unstructured":"Kafal AR, Vinh DC, Langelier MJ. Prefilled syringes for immunoglobulin G (IgG) replacement therapy: clinical experience from other disease settings. Expert Opin Drug Deliv. 2018;15(12):1199\u2013209. https:\/\/doi.org\/10.1080\/17425247.2018.1546692.","journal-title":"Expert Opin Drug Deliv"},{"key":"371_CR6","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.2147\/PPA.S154181","volume":"12","author":"S Vermeire","year":"2018","unstructured":"Vermeire S, D'Heygere F, Nakad A, et al. Preference for a prefilled syringe or an auto-injection device for delivering golimumab in patients with moderate-to-severe ulcerative colitis: a randomized crossover study. Patient Prefer Adherence. 2018;12:1193\u2013202. https:\/\/doi.org\/10.2147\/PPA.S154181.","journal-title":"Patient Prefer Adherence"},{"issue":"3","key":"371_CR7","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.4081\/hpr.2013.e27","volume":"1","author":"K Megari","year":"2013","unstructured":"Megari K. Quality of life in chronic disease patients. Health Psychol Res. 2013;1(3):e27. https:\/\/doi.org\/10.4081\/hpr.2013.e27.","journal-title":"Health Psychol Res"},{"issue":"1","key":"371_CR8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1097\/NCM.0b013e3181b5dec4","volume":"15","author":"J Burton","year":"2010","unstructured":"Burton J, Murphy E, Riley P. Primary immunodeficiency disease: a model for case management of chronic diseases. Prof Case Manag. 2010;15(1):5\u201310, 2-4; quiz 5-6. https:\/\/doi.org\/10.1097\/NCM.0b013e3181b5dec4.","journal-title":"Prof Case Manag"},{"issue":"1","key":"371_CR9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10875-006-8905-x","volume":"26","author":"U Nicolay","year":"2006","unstructured":"Nicolay U, Kiessling P, Berger M, et al. Health-related quality of life and treatment satisfaction in north American patients with primary immunedeficiency diseases receiving subcutaneous IgG self-infusions at home. J Clin Immunol. 2006;26(1):65\u201372. https:\/\/doi.org\/10.1007\/s10875-006-8905-x.","journal-title":"J Clin Immunol"},{"key":"371_CR10","doi-asserted-by":"publisher","first-page":"621","DOI":"10.2147\/ppa.s60771","volume":"8","author":"T Espanol","year":"2014","unstructured":"Espanol T, Prevot J, Drabwell J, et al. Improving current immunoglobulin therapy for patients with primary immunodeficiency: quality of life and views on treatment. Patient Prefer Adherence. 2014;8:621\u20139. https:\/\/doi.org\/10.2147\/ppa.s60771.","journal-title":"Patient Prefer Adherence"},{"issue":"4","key":"371_CR11","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.iac.2008.07.002","volume":"28","author":"M Berger","year":"2008","unstructured":"Berger M. Subcutaneous administration of IgG. Immunol Allergy Clin N Am. 2008;28(4):779\u2013802, viii. https:\/\/doi.org\/10.1016\/j.iac.2008.07.002.","journal-title":"Immunol Allergy Clin N Am"},{"issue":"7","key":"371_CR12","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1007\/s10875-015-0196-7","volume":"35","author":"FO Seeborg","year":"2015","unstructured":"Seeborg FO, Seay R, Boyle M, et al. Perceived health in patients with primary immune deficiency. J Clin Immunol. 2015;35(7):638\u201350. https:\/\/doi.org\/10.1007\/s10875-015-0196-7.","journal-title":"J Clin Immunol"},{"issue":"9","key":"371_CR13","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1097\/SMJ.0b013e3181eba6ea","volume":"103","author":"M Berger","year":"2010","unstructured":"Berger M, Murphy E, Riley P, et al. Improved quality of life, immunoglobulin G levels, and infection rates in patients with primary immunodeficiency diseases during self-treatment with subcutaneous immunoglobulin G. South Med J. 2010;103(9):856\u201363. https:\/\/doi.org\/10.1097\/SMJ.0b013e3181eba6ea.","journal-title":"South Med J"},{"issue":"1","key":"371_CR14","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13223-014-0063-8","volume":"11","author":"AP Koterba","year":"2015","unstructured":"Koterba AP, Stein MR. Initiation of immunoglobulin therapy by subcutaneous administration in immunodeficiency patients naive to replacement therapy. Allergy, Asthma Clin Immunol. 2015;11(1):63. https:\/\/doi.org\/10.1186\/s13223-014-0063-8.","journal-title":"Allergy, Asthma Clin Immunol"},{"issue":"6","key":"371_CR15","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1007\/s10875-012-9720-1","volume":"32","author":"H Abolhassani","year":"2012","unstructured":"Abolhassani H, Sadaghiani MS, Aghamohammadi A, et al. Home-based subcutaneous immunoglobulin versus hospital-based intravenous immunoglobulin in treatment of primary antibody deficiencies: systematic review and meta analysis. J Clin Immunol. 2012;32(6):1180\u201392. https:\/\/doi.org\/10.1007\/s10875-012-9720-1.","journal-title":"J Clin Immunol"},{"key":"371_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s13554-011-0009-3","volume":"1","author":"S Jolles","year":"2011","unstructured":"Jolles S, Stein MR, Longhurst HJ, et al. New Frontiers in subcutaneous immunoglobulin treatment. Biol Ther. 2011;1:3. https:\/\/doi.org\/10.1007\/s13554-011-0009-3.","journal-title":"Biol Ther"},{"issue":"2","key":"371_CR17","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/j.1365-2249.1993.tb03380.x","volume":"92","author":"A Gardulf","year":"1993","unstructured":"Gardulf A, Bjorvell H, Gustafson R, et al. The life situations of patients with primary antibody deficiency untreated or treated with subcutaneous gammaglobulin infusions. Clin Exp Immunol. 1993;92(2):200\u20134. https:\/\/doi.org\/10.1111\/j.1365-2249.1993.tb03380.x.","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"371_CR18","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s10875-017-0404-8","volume":"37","author":"NL Rider","year":"2017","unstructured":"Rider NL, Kutac C, Hajjar J, et al. Health-related quality of life in adult patients with common variable immunodeficiency disorders and impact of treatment. J Clin Immunol. 2017;37(5):461\u201375. https:\/\/doi.org\/10.1007\/s10875-017-0404-8.","journal-title":"J Clin Immunol"},{"key":"371_CR19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2147\/ppa.s24752","volume":"6","author":"CD Barbosa","year":"2012","unstructured":"Barbosa CD, Balp MM, Kulich K, et al. A literature review to explore the link between treatment satisfaction and adherence, compliance, and persistence. Patient Prefer Adherence. 2012;6:39\u201348. https:\/\/doi.org\/10.2147\/ppa.s24752.","journal-title":"Patient Prefer Adherence"},{"issue":"3","key":"371_CR20","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s12325-010-0108-4","volume":"28","author":"M Small","year":"2011","unstructured":"Small M, Anderson P, Vickers A, et al. Importance of inhaler-device satisfaction in asthma treatment: real-world observations of physician-observed compliance and clinical\/patient-reported outcomes. Adv Ther. 2011;28(3):202\u201312. https:\/\/doi.org\/10.1007\/s12325-010-0108-4.","journal-title":"Adv Ther"},{"issue":"6","key":"371_CR21","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1097\/01.mlr.0000166617.68751.5f","volume":"43","author":"R Balkrishnan","year":"2005","unstructured":"Balkrishnan R. The importance of medication adherence in improving chronic-disease related outcomes: what we know and what we need to further know. Med Care. 2005;43(6):517\u201320. https:\/\/doi.org\/10.1097\/01.mlr.0000166617.68751.5f.","journal-title":"Med Care"},{"issue":"1","key":"371_CR22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1001\/jama.1995.03520250075037","volume":"273","author":"IB Wilson","year":"1995","unstructured":"Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA. 1995;273(1):59\u201365.","journal-title":"JAMA."},{"issue":"4","key":"371_CR23","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1093\/intqhc\/mzg042","volume":"15","author":"MS Westaway","year":"2003","unstructured":"Westaway MS, Rheeder P, Van Zyl DG, et al. Interpersonal and organizational dimensions of patient satisfaction: the moderating effects of health status. Int J Qual Health Care. 2003;15(4):337\u201344. https:\/\/doi.org\/10.1093\/intqhc\/mzg042.","journal-title":"Int J Qual Health Care"},{"issue":"6","key":"371_CR24","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s11136-011-0011-8","volume":"21","author":"KF Cook","year":"2012","unstructured":"Cook KF, Bamer AM, Roddey TS, et al. A PROMIS fatigue short form for use by individuals who have multiple sclerosis. Qual Life Res. 2012;21(6):1021\u201330. https:\/\/doi.org\/10.1007\/s11136-011-0011-8.","journal-title":"Qual Life Res"},{"key":"371_CR25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1477-7525-2-12","volume":"2","author":"MJ Atkinson","year":"2004","unstructured":"Atkinson MJ, Sinha A, Hass SL, et al. Validation of a general measure of treatment satisfaction, the treatment satisfaction questionnaire for medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes. 2004;2:12. https:\/\/doi.org\/10.1186\/1477-7525-2-12.","journal-title":"Health Qual Life Outcomes"},{"key":"371_CR26","unstructured":"Health Measures. Patient reported outcome measurement information system (PROMIS) guide 2019 [Available from: http:\/\/www.healthmeasures.net\/]."},{"issue":"5","key":"371_CR27","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jclinepi.2013.10.024","volume":"67","author":"M Rose","year":"2014","unstructured":"Rose M, Bjorner JB, Gandek B, et al. The PROMIS physical function item bank was calibrated to a standardized metric and shown to improve measurement efficiency. J Clin Epidemiol. 2014;67(5):516\u201326. https:\/\/doi.org\/10.1016\/j.jclinepi.2013.10.024.","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"371_CR28","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/j.jclinepi.2010.04.012","volume":"63","author":"NE Rothrock","year":"2010","unstructured":"Rothrock NE, Hays RD, Spritzer K, et al. Relative to the general US population, chronic diseases are associated with poorer health-related quality of life as measured by the patient-reported outcomes measurement information system (PROMIS). J Clin Epidemiol. 2010;63(11):1195\u2013204. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.04.012.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"371_CR29","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/EDE.0b013e3181c30fb2","volume":"21","author":"EW Steyerberg","year":"2010","unstructured":"Steyerberg EW, Vickers AJ, Cook NR, et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology. 2010;21(1):128\u201338. https:\/\/doi.org\/10.1097\/EDE.0b013e3181c30fb2.","journal-title":"Epidemiology."},{"key":"371_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/9781118548387","volume-title":"Applied logistic regression","author":"DW Hosmer","year":"2013","unstructured":"Hosmer DW, Lemeshow S Jr, Sturidvant RX. Applied logistic regression. 3rd ed. Hoboken: Wiley; 2013.","edition":"3"},{"key":"371_CR31","unstructured":"SAS\/STAT(R) 9.2 User's Guide, Second Edition 2019."}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-020-00371-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12865-020-00371-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-020-00371-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T23:22:55Z","timestamp":1628551375000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcimmunol.biomedcentral.com\/articles\/10.1186\/s12865-020-00371-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,10]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["371"],"URL":"https:\/\/doi.org\/10.1186\/s12865-020-00371-y","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,10]]},"assertion":[{"value":"13 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Rajiv Mallick is a full-time employee of and owns stock in CSL Behring, which funded the study. Betsy J. Lahue is a Partner of Alkemi LLC, which has a consultant arrangement with CSL Behring. Paul Bassett is an employee of Meridian HealthComms Ltd. Tiffany Henderson and Christopher Scalchunes are employees of the Immune Deficiency Foundation and have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers\u2019 bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"47"}}